Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 1 day agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 24 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 24 hours ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 1 day agoNovavax NVAX shares surged 45% in Friday’s pre-market trading session having lost 50% of their value...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 24 hours agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 1 day agoShares of Novavax (NVAX 98.66%) are up 12% as of midday Friday following the release of the...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 24 hours agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 1 day agoCash and Cash Equivalents: Ended the quarter with $480.59 million, down from $568.51 million at the end of the previous quarter. On May 10, 2024, Novavax Inc (NASDAQ:NVAX) ...